James Andrew King - Chief Scientific Officer, Chinook Therapeutics, Inc
As of April 13, 2022
What is James Andrew King's Net Worth?
The current estimated net worth of Chinook Therapeutics, Inc's Chief Scientific Officer, James Andrew King, is estimated to be about $350.68K . James Andrew King owns about 5,897 units of Chinook Therapeutics, Inc common stock. In the last 2 years at Chinook Therapeutics, Inc, James Andrew King has sold an estimated value of $286.07K worth.
What is James Andrew King's Past Insider Trading?
James Andrew King's largest purchase order was 5,000 units , worth over $1.75K on April 13, 2022. James Andrew King's largest sale order was 5,000 units , worth over $76.81K on April 13, 2022. In total, James Andrew King has made about 10 transactions over 2 years of their time at Chinook Therapeutics, Inc. James Andrew King usually trades in February, with the busiest year in 2022.
James Andrew King
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is James Andrew King's' Mailing Address?
- Mailing address is C/o Chinook Therapeutics U.S., Inc. 1600 Fairview Ave. E. Seattle WA 98102 WA
What are Chinook Therapeutics, Inc's Past Insider Trades?
Chinook Therapeutics, Inc's most recent insider trade came on June 1, 2022 by Srinivas Akkaraju who bought 570,000 units worth $7.98M . In the last 2 years, insiders at Chinook Therapeutics, Inc have sold an estimated value of $57.56M and bought an estimated value of $27.91M worth of shares. Insider trading is most common in February, with the busiest year in 2021. The most active traders at the company are Eric Dobmeier, President, James Andrew King, Chief Scientific Officer, and Tom Frohlich, Chief Operating Officer .
CHINOOK THERAPEUTICS, INC. Insider Trades
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||